Metered Dose Inhaler Devices Market Report 2026

Metered Dose Inhaler Devices Market Overview

• Metered Dose Inhaler Devices market size has reached to $16.23 billion in 2025 • Expected to grow to $21.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.3% • Growth Driver: Impact Of Rising COPD Prevalence On The Growth Of The Market • Market Trend: Launch Of Affordable Pressurized Metered Dose Inhaler For Asthma And COPD Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Metered Dose Inhaler Devices Market?

Metered dose inhaler (MDI) devices refer to medical devices designed for delivering precise doses of aerosolized medication directly to the lungs through inhalation. These devices are commonly used in the treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other breathing disorders. The main types of metered dose inhaler devices are desktop metered dose inhaler devices, portable metered dose inhaler devices, and other types. A desktop metered dose inhaler is a stationary device used to deliver a measured dose of medication in aerosol form, typically in clinical settings, for treating respiratory conditions. It is distributed through both online and offline channels for various applications, such as asthma, chronic obstructive pulmonary disease, and others. It caters to various end users, such as hospitals, clinics, homecare settings, and other end users.

What Is The Metered Dose Inhaler Devices Market Growth Forecast?

The metered dose inhaler devices market size is expected to see strong growth in the next few years. It will grow to $21.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to growth of smart inhalers, environmental regulations on propellants, homecare treatment expansion, digital adherence monitoring demand, emerging respiratory therapies. Major trends in the forecast period include smart dose tracking inhalers, breath-actuated inhalation technology, compact and portable device designs, dose accuracy enhancement, eco-friendly propellant adoption.

Global Metered Dose Inhaler Devices Market Segmentation

1) By Type: Desktop Metered Dose Inhaler Devices, Portable Metered Dose Inhaler Devices, Other Types 2) By Distribution Channel: Online, Offline 3) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Other Applications 4) By End-User: Hospitals, Clinics, Homecare Settings, Other End Users Subsegments: 1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices, High-performance desktop MDI devices, Smart desktop MDI devices 2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices, Advanced portable MDI devices, Smart portable MDI devices 3) By Other Types: Nebulizer-Based MDI devices, Dry powder inhaler (DPI) combined devices, Soft mist inhaler (SMI) devices, Other specialized MDI devices

What Are The Drivers Of The Metered Dose Inhaler Devices Market?

The increasing prevalence of chronic obstructive pulmonary diseases is expected to propel the growth of the metered dose inhaler devices market going forward. Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by airflow obstruction, typically caused by long-term exposure to irritants such as cigarette smoke, leading to symptoms such as shortness of breath, coughing, and wheezing. The increasing prevalence of chronic obstructive pulmonary disease (COPD) is driven by factors such as tobacco use, air pollution, aging populations, and delayed diagnosis or treatment. Metered dose inhaler (MDI) devices help manage chronic obstructive pulmonary disease (COPD) by delivering medication directly to the lungs, providing fast relief and improving airflow. For instance, in December 2023, according to the National Institutes of Health, a US-based government agency, the number of COPD cases is projected to rise from 532 million in 2030 to a total of 592 million by 2050. Therefore, the increasing prevalence of chronic obstructive pulmonary diseases is driving the growth of the metered dose inhaler devices industry. The rising air pollution are expected to propel the growth of the metered dose inhaler (MDI) devices market going forward. Air pollution refers to the presence of harmful substances, including particulate matter, gases, and biological molecules, in the atmosphere that can cause adverse health effects. Exposure to air pollution is a major risk factor for respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). The rise in air pollution is largely due to industrialization, urbanization, increased vehicular emissions, and the burning of fossil fuels. MDIs support public health by providing targeted medication to manage respiratory conditions triggered or worsened by polluted air. For instance, October 2025, according to the Clean Air Fund UK-based nonprofit philanthropic organization reported that in 2023, funding for fossil fuel–related projects surged 80%, rising from $5.3B to $9.5B due to increasing air pollution. Additionally, fossil fuel combustion contributes to over 5 million of the 8.1 million annual premature air pollution deaths. Therefore, the rising air pollution are driving the growth of the metered dose inhaler devices industry.

Key Players In The Global Metered Dose Inhaler Devices Market

Major companies operating in the metered dose inhaler devices market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline plc, 3M Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Inc., AptarGroup Inc., Philips Healthcare, Chiesi Farmaceutici S.p.A., Cipla Limited, Gerresheimer AG, Zydus Lifesciences Limited, Mylan N.V., Nemera, Beximco Pharmaceuticals Limited, Cohero Health Inc., Bespak Europe Ltd., Trudell Medical International, Iconovo AB

Global Metered Dose Inhaler Devices Market Trends and Insights

Major companies operating in the metered dose inhaler devices market are focused on developing technologically advanced solutions, such as pressurized metered dose inhalers, to enhance drug delivery efficiency and improve patient compliance. Pressurized metered-dose inhalers (pMDIs) are inhalation devices that deliver a precise amount of medication in aerosol form using a pressurized propellant. For instance, in July 2023, Lupin Limited, an India-based pharmaceutical company, launched Luforbec 100/6, a pressurized metered dose inhaler (pMDI) for the treatment of adult asthma and chronic obstructive pulmonary disease (COPD) in Germany. This product combines beclometasone (100 µg) and formoterol (6 µg), providing an effective solution for patients requiring combination therapy. Notably, Luforbec is priced approximately 47% lower than the fixed reference price, enhancing its accessibility. With asthma affecting about 5% of adults in Germany, this launch underscores Lupin's commitment to addressing critical healthcare needs and improving patient outcomes in respiratory care.

Regional Outlook

North America was the largest region in the metered dose inhaler devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Metered Dose Inhaler Devices Market?

The metered dose inhaler devices market consists of sales of products including bronchodilators, corticosteroids, combination inhalers, and anticholinergics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.